此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

高级气管插管进行高级支气管镜检查的深层镇静剂

2026年9月15日 更新者:Hee Yun Seol、Pusan National University Yangsan Hospital

关于在程序主义方向下深层镇静的安全性和可行性的观察性前瞻性研究,并进行了先发制性气管插管,用于先进的支气管镜检查程序

Bronchoscopy is crucial for diagnosing and treating respiratory diseases and is recommended under sedation. Deep sedation improves patient comfort and procedural efficiency, especially in complex cases, by reducing movement and coughing. However, it carries risks of respiratory depression and airway obstruction, potentially requiring premature termination or urgent intubation. Determining the optimal timing for intubation can be challenging despite proper monitoring. To enhance safety, the investigator has performed bronchoscopy under deep sedation with preemptive intubation for years, sharing this experience with other hospitals. This study aims to evaluate its safety and feasibility through a multicenter prospective observational approach.

研究概览

详细说明

Bronchoscopy is a crucial procedure for diagnosing and treating respiratory diseases. It is recommended to be performed under sedation whenever possible, with sedation levels ranging from minimal to moderate and deep sedation. Deep sedation enhances patient comfort and facilitates the procedure, making it particularly useful for lengthy or complex bronchoscopic examinations. Additionally, deep sedation reduces involuntary patient movements and coughing, allowing the proceduralist to perform bronchoscopy more effectively when the patient is deeply sedated.

Despite its benefits, deep sedation carries the risk of respiratory depression and impaired airway maintenance, which may necessitate early termination of the bronchoscopy. If respiratory suppression or inadequate airway maintenance occurs during deep sedation, the procedure may need to be interrupted for endotracheal intubation using the bronchoscope. However, even with appropriate monitoring during bronchoscopy, determining the optimal timing for endotracheal intubation can be challenging, potentially disrupting procedural continuity and reducing the likelihood of a successful examination.

To enhance patient comfort and procedural safety, the investigator has been performing bronchoscopy under deep sedation with preemptive endotracheal intubation for several years. This clinical experience has been shared with other university hospitals in the region, and cases of deep sedation with preemptive intubation under the supervision of bronchoscopists have been reported. This study aims to evaluate the safety and feasibility of deep sedation with preemptive endotracheal intubation during bronchoscopy through a multicenter prospective observational approach.

研究类型

观察性的

注册 (实际的)

191

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Yangsan、韩国
        • Pusan National University Yangsan Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

19年 至 90年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients with pulmonary lesions

描述

Inclusion Criteria:

  • Patients requiring a bronchoscopy-assisted procedure for diagnostic or therapeutic purposes
  • Individuals who voluntarily consent to participate in the clinical study and sign a written informed consent form

Exclusion Criteria:

  • Patients who have experienced acute myocardial infarction or acute stroke within the past six weeks
  • Patients with contraindications to bronchoscopy (e.g., severe respiratory or cardiovascular comorbidities)
  • Patients with a history of allergy to benzodiazepines, propofol, fentanyl, or flumazenil
  • Patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
  • Patients with a severe hypersensitivity reaction to dextran 40
  • Patients with a history of acute angle-closure glaucoma
  • Pregnant women
  • Prisoners
  • Patients with psychiatric disorders
  • Patients classified as ASA Physical Status IV or V by the American Society of Anesthesiologists (ASA)
  • Any other patients deemed unsuitable for the clinical study by the investigator

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
需要进行支气管镜检查程序的患者以进行诊断或治疗目的

If an eligible subject consents to participate in the study, deep sedation and preemptive endotracheal intubation will be performed, followed by bronchoscopy. Deep sedation will be administered according to the study protocol, with final approval of sedative administration given by the proceduralist. Oxygen will be supplied at a flow rate of 4-6 L/min via a nasal cannula before sedative administration.

To achieve a deep sedation state (Modified Observer's Assessment of Alertness/Sedation [MOAA/S] score ≤ 2, defined as the patient not opening their eyes despite repeated verbal stimuli), an initial dose of 50 mcg fentanyl will be administered, followed by 2.5-5 mg of remimazolam. The sedation depth will be assessed every two minutes using the MOAA/S score. If the patient has not reached deep sedation, an additional 2.5 mg of remimazolam will be administered.

Once deep sedation is achieved, lidocaine will be sprayed onto the trachea and bronchi using a bronchoscope for local anesthe

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The incidence of hypoxia during deep sedation under proceduralist guidance with endotracheal intubation
大体时间:On the day of the bronchoscopy procedure, from the initiation of sedation therapy to the completion of the bronchoscopy procedure.

This study investigates the incidence of hypoxia during deep sedation under the proceduralist's guidance with endotracheal intubation. Hypoxia is defined as an oxygen saturation of less than 94% sustained for more than 10 seconds during the procedure.

On the day of the bronchoscopy procedure, from the initiation of sedation therapy to the completion of the bronchoscopy procedure.

次要结果测量

结果测量
措施说明
大体时间
The incidence of severe hypoxia during deep sedation under proceduralist guidance with endotracheal intubation
大体时间:On the day of the bronchoscopy procedure, from the initiation of sedation therapy to the completion of the bronchoscopy procedure.

This study investigates the incidence of hypoxia during deep sedation under the proceduralist's guidance with endotracheal intubation. Hypoxia is defined as an oxygen saturation of less than 90% sustained for more than 60 seconds during the procedure.

On the day of the bronchoscopy procedure, from the initiation of sedation therapy to the completion of the bronchoscopy procedure.
The incidence of complications
大体时间:From the day of the bronchoscopy procedure to the outpatient visit one week after the procedure.

early termination or delay of the procedure, complications from endotracheal intubation, complications from bronchoscopy

From the day of the bronchoscopy procedure to the outpatient visit one week after the procedure.
The rate of patient satisfaction
大体时间:From the completion of the bronchoscopy procedure to the point when the patient has fully recovered from sedation.

Patient satisfaction immediately after the procedure is assessed by two items: distress during fiberoptic bronchoscopy (distress/ tolerable/ no distress or satisfied) and willingness to be reexamined (accept/ never again).

From the completion of the bronchoscopy procedure to the point when the patient has fully recovered from sedation.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Hee Yun Seol, MD, PhD、Pusan National University Yangsan Hospital, Yangsan, South Korea

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年4月8日

初级完成 (实际的)

2026年3月31日

研究完成 (实际的)

2026年3月31日

研究注册日期

首次提交

2025年3月14日

首先提交符合 QC 标准的

2025年3月14日

首次发布 (实际的)

2025年3月20日

研究记录更新

最后更新发布 (实际的)

2026年9月18日

上次提交的符合 QC 标准的更新

2026年9月15日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 11-2025-013

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅